We are live on ! Find out more
FM

Frazier Management Portfolio holdings

AUM $1.12M
1-Year Est. Return 151.58%
This Fund
S&P 500
This Quarter Est. Return
+5.06%
1 Year Est. Return
+151.58%
3 Year Est. Return
+408.4%
5 Year Est. Return
+1,802.6%
10 Year Est. Return
AUM
$239M
AUM Growth
Cap. Flow
+$221M
Cap. Flow %
92.59%
Top 10 Hldgs %
100%
Holding
7
New
7
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GKOS icon
1
Glaukos
GKOS
$10.7B
$64.3M 26.88%
+2,603,362
New +$59.7M
COLL icon
2
Collegium Pharmaceutical
COLL
$820M
$51.6M 21.59%
+1,877,332
New +$39.6M
SRRA
3
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$32.9M 13.75%
+54,655
New +$37M
FOLD
4
DELISTED
Amicus Therapeutics
FOLD
$28.3M 11.84%
+2,918,291
New +$26.3M
TBRA
5
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$26.8M 11.21%
+2,668,570
New +$27.7M
CDTX
6
DELISTED
Cidara Therapeutics
CDTX
$22.5M 9.42%
+65,613
New +$19.7M
RXDX
7
DELISTED
Ignyta, Inc.
RXDX
$12.7M 5.32%
+950,366
New +$11.5M

Similar funds

Frazier Management's Q4 2015 Portfolio in Review

Q4 2015 is the first quarter with a 13F filing on record for Frazier Management, which disclosed 7 positions worth $239M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Glaukos: 2,603,362 shares worth $64.3M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Frazier Management's largest Q4 2015 buy was Glaukos: 2,603,362 shares worth $64.3M.
  • Frazier Management's ten largest holdings make up 100% of its $239M portfolio in Q4 2015.
  • Frazier Management disclosed 7 positions in Q4 2015, its first 13F filing on record.

Based on Frazier Management's 13F filing for Q4 2015, filed 11 Feb 2016.